C-Rad
40.1 SEK +0.25%Be the first to follow this company
C-Rad is active in medical technology. The company conducts the development, manufacturing, and sales of products and solutions in advanced radiation therapy. The business is mainly aimed at clinics that offer radiation treatment, where the company in addition to its core business offers associated installation services and support. The customers are located on a global level and the head office is located in Uppsala.
Revenue
424.6M
EBIT %
13.54 %
P/E
29.49
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
CRAD B
Daily low / high price
39.05 / 40.1
SEK
Market cap
1.35B SEK
Turnover
905.77K SEK
Volume
23K
Financial calendar
Interim report
2024-05-14
General meeting
2024-05-15
Interim report
2024-07-18
Interim report
2024-10-23
Annual report
2025-02-07
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Svea Ekonomi AB | 11.9 % | 11.9 % |
Lars Kling | 7.9 % | 10.4 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Finansinspektionen: Flaggningsmeddelande i C-Rad AB
KALLELSE TILL ÅRSSTÄMMA I C-RAD AB (PUBL)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools